| JYSB2300011 | 古塞奇尤单抗注射液 | guselkumab | Injection | Biological Products | Supplementary Application | 2023-01-17 | | Cilag AG;Janssen-Cilag International NV | | | view |
| JYSB2000420 | 古塞奇尤单抗注射液 | guselkumab | Injection | Biological Products | Supplementary Application | 2020-08-27 | Janssen-Cilag International NV | Janssen-Cilag International NV;Cilag AG | In Review | 2020-08-26 | view |
| JXSS2500022 | 古塞奇尤单抗注射液 | guselkumab | Injection | Biological Products(2.2) | Import Drug Application | 2025-03-06 | | Xian Janssen Pharmaceutical Ltd;Cilag AG;Janssen-Cilag International NV | | | view |
| JXSB2300126 | 古塞奇尤单抗注射液 | guselkumab | Injection | Biological Products(2.2) | Supplementary Application | 2023-10-19 | | Cilag AG;Janssen Research & Development LLC | | | view |
| JYSB2200149 | 古塞奇尤单抗注射液 | guselkumab | Injection | Biological Products | Supplementary Application | 2022-08-30 | | Cilag AG;Janssen Research & Development LLC | | | view |
| JYSZ2400022 | 古塞奇尤单抗注射液 | guselkumab | Injection | Biological Products | License Renew | 2024-05-06 | | Cilag AG;Xian Janssen Pharmaceutical Ltd;Janssen-Cilag International NV | | | view |
| JXSL2101113 | 古塞奇尤单抗注射液 | guselkumab | Injection | Biological Products(2.2) | Import Drug Application | 2021-09-29 | | Janssen Research & Development LLC;Johnson & Johnson (CHINA) Investment Ltd | | | view |
| JYSB2000089 | 古塞奇尤单抗注射液 | guselkumab | Injection | Biological Products | Supplementary Application | 2020-03-24 | Janssen-Cilag International NV | Janssen-Cilag International NV;Cilag AG | Filed | 2020-03-30 | view |
| JXSB2400119 | 古塞奇尤单抗注射液 | guselkumab | Injection | Biological Products(2.2) | Supplementary Application | 2024-08-15 | | Cilag AG;Janssen Research & Development LLC | | | view |
| JXSL2300109 | 古塞奇尤单抗注射液 | guselkumab | Injection | Biological Products(2.2) | Import Drug Application | 2023-06-16 | | Janssen Research & Development LLC;Johnson & Johnson (CHINA) Investment Ltd | | | view |
| JYSB2100074 | 古塞奇尤单抗注射液 | guselkumab | Injection | Biological Products | Supplementary Application | 2021-03-12 | Janssen-Cilag International NV | Janssen-Cilag International NV;Cilag AG | In Review | 2021-03-12 | view |
| JXSS2400027 | 古塞奇尤单抗注射液 | guselkumab | Injection | Biological Products(2.2) | Import Drug Application | 2024-03-27 | | Cilag AG;Xian Janssen Pharmaceutical Ltd;Janssen-Cilag International NV | | | view |
| JYSB2200211 | 古塞奇尤单抗注射液 | guselkumab | Injection | Biological Products | Supplementary Application | 2022-11-15 | | Cilag AG;Janssen-Cilag International NV | | | view |
| JXSS2400053 | 古塞奇尤单抗注射液 | guselkumab | Injection | Biological Products(2.2) | Import Drug Application | 2024-07-03 | | Cilag AG;Xian Janssen Pharmaceutical Ltd;Janssen-Cilag International NV | | | view |
| JXSS2400104 | 古塞奇尤单抗注射液 | guselkumab | Injection | Biological Products(2.2) | Import Drug Application | 2024-11-27 | | Cilag AG;Xian Janssen Pharmaceutical Ltd;Janssen-Cilag International NV | | | view |
| JXSL2300153 | 古塞奇尤单抗注射液 | guselkumab | Injection | Biological Products(2.2) | Import Drug Application | 2023-08-18 | | Janssen Research & Development LLC;Johnson & Johnson (CHINA) Investment Ltd | | | view |
| JXSL2200033 | 古塞奇尤单抗注射液 | guselkumab | Injection | Biological Products(2.2) | Import Drug Application | 2022-03-22 | | Janssen Research & Development LLC;Johnson & Johnson (CHINA) Investment Ltd | | | view |
| JYSZ2400021 | 古塞奇尤单抗注射液 | guselkumab | Injection | Biological Products | License Renew | 2024-05-06 | | Cilag AG;Xian Janssen Pharmaceutical Ltd;Janssen-Cilag International NV | | | view |
| JYSB2101189 | 古塞奇尤单抗注射液 | guselkumab | Injection | Biological Products | Supplementary Application | 2021-12-09 | | Cilag AG;Janssen-Cilag International NV | | | view |
| JXSB2400118 | 古塞奇尤单抗注射液 | guselkumab | Injection | Biological Products(2.2) | Supplementary Application | 2024-08-15 | | Cilag AG;Janssen Research & Development LLC | | | view |
